What the Midterm Election Results Mean for Parkinson’s Policy
🧠 What will you learn in this article?
- Democrats will control the U.S. House and Senate starting in January. New committee leaders will shape which bills get hearings and what Congress prioritizes in funding negotiations.
- The Parkinson’s Foundation will work with federal lawmakers from both parties to reintroduce the Paraquat Prevention Act and with state advocates to build on Vermont’s first-in-the-nation paraquat ban.
- Congress temporarily blocked proposed changes to federal grant rules through December 11. The Foundation is urging lawmakers to extend those protections for medical research and clinical trials.
- The National Parkinson’s Project Advisory Council discussed partnerships to improve Parkinson’s treatments and diagnosis in November.
With a new U.S. House and Senate taking office in January, what could this mean for policies that can create change for people with Parkinson’s disease (PD)?
Democrats won control of the U.S. House and Senate in the midterm elections and will take over both chambers when the new Congress convenes. New committee leaders will help decide which bills get hearings, what Congress prioritizes in funding negotiations and how lawmakers oversee federal agencies.
With a Republican administration still in office, support across party lines will remain important to getting legislation signed into law. The Parkinson’s Foundation works with champions in both parties to advance policies that improve life for people with Parkinson’s.
Building Relationships in the New Congress
Some incoming lawmakers bring experience caring for people with Parkinson’s. Others know the disease through their own families. Those experiences may make some lawmakers more receptive to hearing directly from advocates about what it takes to get a diagnosis, find specialized care or support a loved one as the disease progresses.
We’ll use those conversations to show how specific policies can improve access to affordable Parkinson’s care, protect research funding and reduce exposure to pesticides linked to developing Parkinson's.
In January, the Foundation will continue meeting with committee leaders and staff who shape health policy and research funding and build relationships with newly elected lawmakers whose work intersects with our priorities.
We’ll work with returning champions from both parties to reintroduce priority bills, including the bipartisan Paraquat Prevention Act, and recruit new cosponsors. At the Parkinson’s Policy Forum in March, advocates will bring those requests directly to their members of Congress on Capitol Hill.
Protecting and Promoting Research
Temporary funding for research that supports Parkinson’s through the federal government runs through December 11. The same funding law temporarily blocked proposed changes to federal grant rules from the Office of Management and Budget (OMB). The proposal would make it easier for political appointees to terminate grants midstream, putting long-term studies and clinical trials at risk.
As lawmakers negotiate the next funding bill, we’re urging Congress to extend those protections and sustain funding for medical research. In the new Congress, we’ll continue to press for stable research funding and grant decisions guided by scientific expertise.
Tell Congress to protect medical research
Building on State Momentum to Reduce Paraquat Exposure
Across the country, new state legislators and governors will also take office in January. We’ll build on state advocacy successes in 2026, including Vermont’s first-in-the-nation paraquat ban.
Research has linked exposure to the pesticide to an increased risk of Parkinson’s. In addition to Vermont, California (the nation’s largest agricultural state) is phasing out paraquat, and 13 other states and one territory introduced legislation to ban or restrict paraquat in 2026.
The Parkinson’s Foundation will work with local advocates and coalition partners to urge more states to protect their residents while we continue to push for a nationwide ban.
An Update on the National Plan to End Parkinson’s
On November 9, the federal Advisory Council held its first hybrid meeting. The discussion focused on how government, researchers and industry can work together to develop better treatments and tools for diagnosing Parkinson’s.
During public comment, Parkinson’s Foundation board member Christina Weaver Jackson shared how her father’s diagnosis changed life for their family.
Christina Weaver Jackson
“It has been hard to watch what Parkinson’s has done to my dad, but it has motivated me to support the Parkinson’s Foundation so that others have a better experience in the future, and so one day, no one has to deal with this disease anymore,” said Christina Weaver Jackson.
The Foundation also submitted written comments and helped lead a joint letter signed by 35 organizations in the Unified Parkinson’s Advocacy Council outlining priorities for the National Plan.
The Advisory Council is still developing its recommendations, and the Foundation is gathering signatures ahead of its December 7 meeting to show what the Parkinson’s community wants the National Plan to prioritize. Add your name by November 23.
Want more Parkinson’s policy updates? Sign up for our Advocacy Network emails and encourage friends and family to sign up on our Advocacy Center.
Related Blog Posts
Protecting the Research People with Parkinson’s Are Counting On
Six Priorities for the National Plan to End Parkinson’s: What We Heard From the Parkinson’s Community